Efficacy of mRNA Vaccines in Preventing Long COVID: A 12-Month Follow-up Study
This large-scale RCT demonstrates significant reduction in long COVID symptoms among vaccinated individuals, with 68% lower incidence of persistent symptoms at 12 months post-infection.
Key Findings:
- •68% reduction in long COVID symptoms
- •Significant improvement in fatigue and cognitive function
- •Lower hospitalization rates in vaccinated cohort